Treatment of Primary Menstrual Pain With Kanion Capsule

Lianyungang Kanion Group, Ltd.

Overview

The objectives of this clinical trial are: * To further study the safety of Kanion Capsule (GF) in primary dysmenorrhea subjects; * To further evaluate the efficacy of GF in treatment of primary dysmenorrhea.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Conditions

Primary Dysmenorrhea

Interventions

Kanion CapsuleDRUG

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * primary dysmenorrhea Exclusion Criteria: * secondary dysmenorrhea

Locations (1)

Mount Vernon Clinical Research, LLC

Sandy Springs, Georgia, United States

Outcomes

Primary Outcomes

pain reduction

Time frame: 6 months

Secondary Outcomes

accompanying symptoms improvement

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.